Natural killer cells in the treatment of high-risk acute leukaemia

Medicine and Dentistry

• Acute Leukemia 100%
• Natural Killer Cell 100%
• Therapeutic Procedure 100%
• Donor 100%
• Receptor 42%
• Inpatient 42%
• Antigen Presenting Cell 28%
• Allogeneic Hematopoietic Stem Cell Transplantation 28%
• Clinical Study 14%
• Biological Product 14%
• Transplantation 14%
• Hematologic Malignancy 14%
• Neoplasm 14%
• Infusion 14%
• Cancer Cell 14%
• Therapy Effect 14%
• Solid Malignant Neoplasm 14%
• Ex Vivo 14%
• Cell Therapy 14%
• Innate Immunity 14%
• Ligand 14%
• Haplotype 14%
• Allograft 14%
• Cytomegalovirus Infection 14%
• Adaptive Immunity 14%
• Graft Rejection 14%
• Graft Versus Host Reaction 14%
• Patient 14%
• Cells 14%
• Volunteer 14%
• Clinical Trial 14%
• Cytotoxic T-Cell 14%

Immunology and Microbiology

• Natural Killer Cell 100%
• Allogeneic Hematopoietic Stem Cell Transplantation 28%
• Biological Product 14%
• Innate Immune System 14%
• Cytotoxic T Cell 14%
• Haplotype 14%
• Transplantation 14%
• Cytomegalovirus Infection 14%
• Cancer Cell 14%
• Adaptive Immune System 14%
• Allotransplantation 14%
• Transplant Rejection 14%
• Graft-Versus-Host Disease 14%
• Solid 14%
• Cells 14%